Sign in to view content

Episode 1: Review of the Clarity Study with Dr. Amin Kherani

Keyvan Koushan, MD, FRCSC

Audio
Published 2017

Related

APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies
Michael J Allingham, MD, PhD
Annual Meeting Talks
2021
Intravitreal Injections: Logistics, Safety, and Pearls
Andrew A. Moshfeghi, MD, MBA, FASRS
Webinars and Journal Clubs
2018
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019

Category: Diabetic Retinopathy

See more